{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:42:55Z","timestamp":1776984175410,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62371243"],"award-info":[{"award-number":["62371243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Key Research and Development Program Social Development Project","award":["BE2022720"],"award-info":[{"award-number":["BE2022720"]}]},{"name":"the National Natural Science Foundation of Jiangsu","award":["BK20231190"],"award-info":[{"award-number":["BK20231190"]}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit of Oncology Therapeutics","award":["JSDW202237"],"award-info":[{"award-number":["JSDW202237"]}]},{"name":"General Program of Jiangsu Provincial Health Commission","award":["M2020006"],"award-info":[{"award-number":["M2020006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02253-y","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:55:03Z","timestamp":1773464103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretable deep learning radiomics from 18F-FDG PET\/CT for differentiating diffuse large B-cell lymphoma and follicular lymphoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Chaoying","family":"Liu","sequence":"first","affiliation":[]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Zhuxia","family":"Jia","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Xiaoliang","family":"Shao","sequence":"additional","affiliation":[]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Mengmiao","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Xinye","family":"Ni","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"1","key":"2253_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA"},{"issue":"5","key":"2253_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.seminhematol","volume":"60","author":"SS Wang","year":"2023","unstructured":"Wang SS. Epidemiology and etiology of diffuse large B-cell lymphoma. Semin Hematol. 2023;60(5):255\u201366. https:\/\/doi.org\/10.1053\/j.seminhematol.","journal-title":"Semin Hematol"},{"issue":"1","key":"2253_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-023-00525-1","volume":"11","author":"JL Vaughn","year":"2023","unstructured":"Vaughn JL, Epperla N. Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort study. Biomarkr Res. 2023;11(1):84. https:\/\/doi.org\/10.1186\/s40364-023-00525-1.","journal-title":"Biomarkr Res"},{"issue":"8","key":"2253_CR4","doi-asserted-by":"publisher","first-page":"e7120","DOI":"10.1002\/cam4.7120","volume":"13","author":"W Zheng","year":"2024","unstructured":"Zheng W, Liu M, Guan L, et al. Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: a population-based study. Cancer Med. 2024;13(8):e7120. https:\/\/doi.org\/10.1002\/cam4.7120.","journal-title":"Cancer Med"},{"issue":"19","key":"2253_CR5","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/cncr.35378","volume":"130","author":"Z-H Li","year":"2024","unstructured":"Li Z-H, Zhang M-Y, Federico M, et al. Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: a population-based analysis and validation. Cancer. 2024;130(19):3321\u201332. https:\/\/doi.org\/10.1002\/cncr.35378.","journal-title":"Cancer"},{"key":"2253_CR6","doi-asserted-by":"publisher","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32 (27):048\u20133058. https:\/\/doi.org\/10.1200\/JCO.2013.53.5229","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"2253_CR7","doi-asserted-by":"publisher","unstructured":"Lovinfosse P, Ferreira M, Withofs N, et al. Distinction of lymphoma from sarcoidosis on 18F-FDG PET\/CT: evaluation of radiomics-feature\u2013guided machine learning versus human reader performance. J Nucl Med. 2022;63 (12):1933. https:\/\/doi.org\/10.2967\/jnumed.121.263598","DOI":"10.2967\/jnumed.121.263598"},{"issue":"1","key":"2253_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40779-023-00458-8","volume":"10","author":"Y-P Zhang","year":"2023","unstructured":"Zhang Y-P, Zhang X-Y, Cheng Y-T, et al. Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling. Military Med Res. 2023;10(1):22. https:\/\/doi.org\/10.1186\/s40779-023-00458-8.","journal-title":"Military Med Res"},{"issue":"4","key":"2253_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, et al. Introduction radiomics J Nucl Med. 2020;61(4):488. https:\/\/doi.org\/10.2967\/jnumed.118.222893.","journal-title":"Introduction radiomics J Nucl Med"},{"issue":"5","key":"2253_CR10","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1007\/s00330-022-09301-5","volume":"33","author":"M Li","year":"2023","unstructured":"Li M, Yao H, Zhang P, et al. Development and validation of a 18F-FDG PET\/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients. Eur Radiol. 2023;33(5):3354\u201365. https:\/\/doi.org\/10.1007\/s00330-022-09301-5.","journal-title":"Eur Radiol"},{"issue":"6","key":"2253_CR11","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.3390\/curroncol28060383","volume":"28","author":"F Huber","year":"2021","unstructured":"Huber F, Zwickl-Traxler E, Pecherstorfer M, et al. Evaluation of Ki-67 as a prognostic marker in diffuse large B-cell lymphoma: a single-center retrospective cohort study. Curr Oncol. 2021;28(6):4521\u20139. https:\/\/doi.org\/10.3390\/curroncol28060383.","journal-title":"Curr Oncol"},{"key":"2253_CR12","doi-asserted-by":"publisher","unstructured":"qbal J, Meyer PF, Smith LM, Johnson NA, et al. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab. Clin Cancer Res. 2011;17(24):7785-95. https:\/\/doi.org\/10.1158\/1078-0432","DOI":"10.1158\/1078-0432"},{"issue":"11","key":"2253_CR13","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","volume":"21","author":"J Iqbal","year":"2007","unstructured":"Iqbal J, Greiner TC, Patel K, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia. 2007;21(11):2332\u201343. https:\/\/doi.org\/10.1038\/sj.leu.2404856.","journal-title":"Leukemia"},{"issue":"2","key":"2253_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2253_CR15","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1038\/s41598-021-89114-6","volume":"11","author":"E Chang","year":"2021","unstructured":"Chang E, Joel M, Chang HY, et al. Comparison of radiomic feature aggregation methods for patients with multiple tumors. Sci Rep. 2021;11(1):9758. https:\/\/doi.org\/10.1038\/s41598-021-89114-6.","journal-title":"Sci Rep"},{"issue":"27","key":"2253_CR16","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059\u201368. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2253_CR17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12880-025-01937-1","volume":"25","author":"E Tr\u00e4g\u00e5rdh","year":"2025","unstructured":"Tr\u00e4g\u00e5rdh E, Lewold M, Urdaneta JL, et al. Inter-reader agreement of quantitative FDG PET\/CT biomarkers in lymphoma: a multicentre evaluation of MTV, TLG and Dmax. BMC Med Imaging. 2025;25(1):368. https:\/\/doi.org\/10.1186\/s12880-025-01937-1.","journal-title":"BMC Med Imaging"},{"issue":"9","key":"2253_CR18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/annonc\/mdp030","volume":"20","author":"JYY Ngeow","year":"2009","unstructured":"Ngeow JYY, Quek RHH, Ng DCE, et al. High SUV uptake on FDG-PET\/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET\/CT staging in lymphoma. Ann Oncol. 2009;20(9):1543\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdp030.","journal-title":"Ann Oncol"},{"issue":"3","key":"2253_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","volume":"20","author":"A Noy","year":"2009","unstructured":"Noy A, Sch\u00f6der H, G\u00f6nen M, et al. The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol. 2009;20(3):508\u201312. https:\/\/doi.org\/10.1093\/annonc\/mdn657.","journal-title":"Ann Oncol"},{"issue":"7","key":"2253_CR20","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3324\/haematol.2019.230649","volume":"105","author":"P Strati","year":"2020","unstructured":"Strati P, Ahmed MA, Fowler NH, et al. Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma. Haematologica. 2020;105(7):1907\u201313. https:\/\/doi.org\/10.3324\/haematol.2019.230649.","journal-title":"Haematologica"},{"issue":"15","key":"2253_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood.2019001091","volume":"135","author":"F Mir","year":"2020","unstructured":"Mir F, Barrington SF, Brown H, et al. Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study. Blood. 2020;135(15):1214\u20138. https:\/\/doi.org\/10.1182\/blood.2019001091.","journal-title":"Blood"},{"issue":"2","key":"2253_CR22","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/S2589-7500(23)00203-0","volume":"6","author":"I H\u00e4ggstr\u00f6m","year":"2024","unstructured":"H\u00e4ggstr\u00f6m I, Leithner D, Alv\u00e9n J, et al. Deep learning for 18F-FDG PET\/CT classification in patients with lymphoma: a dual-centre retrospective analysis. Lancet Digit Health. 2024;6(2):e114\u201325. https:\/\/doi.org\/10.1016\/S2589-7500(23)00203-0.","journal-title":"Lancet Digit Health"},{"issue":"5","key":"2253_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00259-021-05626-3","volume":"49","author":"FM de Jesus","year":"2022","unstructured":"de Jesus FM, Yin Y, Mantzorou-Kyriaki E, et al. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic 18F-FDG PET\/CT features. Eur J Nucl Med Mol Imaging. 2022;49(5):1535\u201343. https:\/\/doi.org\/10.1007\/s00259-021-05626-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2253_CR24","doi-asserted-by":"crossref","unstructured":"He K, Zhang X, Ren S, Recognition P, et al. Deep residual learning for image recognition. In (CVPR), Las Vegas, NV, USA; 2016.","DOI":"10.1109\/CVPR.2016.90"},{"issue":"1","key":"2253_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12880-024-01241-4","volume":"24","author":"V Kumar","year":"2024","unstructured":"Kumar V, Prabha C, Sharma P, et al. Unified deep learning models for enhanced lung cancer prediction with ResNet-50-101 and EfficientNet-B3 using DICOM images. BMC Med Imaging. 2024;24(1):63. https:\/\/doi.org\/10.1186\/s12880-024-01241-4.","journal-title":"BMC Med Imaging"},{"issue":"14","key":"2253_CR26","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.3390\/cancers15143608","volume":"15","author":"X Jiang","year":"2023","unstructured":"Jiang X, Hu Z, Wang S, et al. Deep learning for medical image-based cancer diagnosis. Cancers (Basel). 2023;15(14):3608. https:\/\/doi.org\/10.3390\/cancers15143608.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2253_CR27","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.21037\/qims-22-1333","volume":"13","author":"W Chen","year":"2023","unstructured":"Chen W, Liu F, Wang R, et al. End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma. Quant Imaging Med Surg. 2023;13(10):6598\u2013614. https:\/\/doi.org\/10.21037\/qims-22-1333.","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"2253_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/jpm13030539","volume":"13","author":"C Cui","year":"2023","unstructured":"Cui C, Yao X, Xu L, et al. Improving the classification of PCNSL and brain metastases by developing a machine learning model based on 18F-FDG PET. J Pers Med. 2023;13(3):539. https:\/\/doi.org\/10.3390\/jpm13030539.","journal-title":"J Pers Med"},{"issue":"2","key":"2253_CR29","doi-asserted-by":"publisher","first-page":"e3266","DOI":"10.1002\/hon.3266","volume":"42","author":"D Albano","year":"2024","unstructured":"Albano D, Calabr\u00f2 A, Dondi F, et al. The role of baseline 2-[18 F]-FDG-PET\/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis. Hematol Oncol. 2024;42(2):e3266. https:\/\/doi.org\/10.1002\/hon.3266.","journal-title":"Hematol Oncol"},{"key":"2253_CR30","doi-asserted-by":"publisher","first-page":"9919269","DOI":"10.1155\/2023\/9919269","volume":"2023","author":"Q Xu","year":"2023","unstructured":"Xu Q, Xie W, Liao B, et al. Interpretability of clinical decision support systems based on artificial intelligence from technological and medical perspective: a systematic review. J Healthc Eng. 2023;2023:9919269. https:\/\/doi.org\/10.1155\/2023\/9919269.","journal-title":"J Healthc Eng"},{"issue":"5","key":"2253_CR31","doi-asserted-by":"publisher","first-page":"e2212930","DOI":"10.1001\/jamanetworkopen.2022.12930","volume":"5","author":"H Deng","year":"2022","unstructured":"Deng H, Eftekhari Z, Carlin C, et al. Development and validation of an explainable machine learning model for major complications after cytoreductive surgery. JAMA Netw Open. 2022;5(5):e2212930. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.12930.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2253_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/bioengineering12080879","volume":"12","author":"Y Singh","year":"2025","unstructured":"Singh Y, Hathaway QA, Keishing V, et al. Beyond Post hoc Explanations: a comprehensive framework for accountable AI in medical imaging through transparency, interpretability, and explainability. Bioeng (Basel). 2025;12(8):879. https:\/\/doi.org\/10.3390\/bioengineering12080879.","journal-title":"Bioeng (Basel)"},{"issue":"12","key":"2253_CR33","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1007\/s00330-022-08887-0","volume":"32","author":"Y Wang","year":"2022","unstructured":"Wang Y, Lang J, Zuo JZ, et al. The radiomic-clinical model using the SHAP method for assessing the treatment response of whole-brain radiotherapy: a multicentric study. Eur Radiol. 2022;32(12):8737\u201347. https:\/\/doi.org\/10.1007\/s00330-022-08887-0.","journal-title":"Eur Radiol"},{"issue":"5","key":"2253_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00259-019-04500-7","volume":"47","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao N, Wu Z, et al. New insight on the correlation of metabolic status on 18F-FDG PET\/CT with immune marker expression in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2020;47(5):1127\u201336. https:\/\/doi.org\/10.1007\/s00259-019-04500-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2253_CR35","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00259-022-05780-2","volume":"49","author":"E Lopci","year":"2022","unstructured":"Lopci E, Hicks RJ, Dimitrakopoulou-Strauss A, et al. Joint EANM\/SNMMI\/ANZSNM practice guidelines\/procedure standards on recommended use of [18F]FDG PET\/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0. Eur J Nucl Med Mol Imaging. 2022;49(7):2323\u201341. https:\/\/doi.org\/10.1007\/s00259-022-05780-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2253_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13244-024-01840-3","volume":"15","author":"Z Wei","year":"2024","unstructured":"Wei Z, Bai X, Xv Y, et al. A radiomics-based interpretable machine learning model to predict the HER2 status in bladder cancer: a multicenter study. Insights Imaging. 2024;15(1):262. https:\/\/doi.org\/10.1186\/s13244-024-01840-3.","journal-title":"Insights Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02253-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:26:03Z","timestamp":1776983163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02253-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02253-y","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Medical Ethics Committee of the Third Affiliated Hospital of Nanjing Medical University approved this retrospective study (No. [2024] KY107-01). As it was a retrospective study, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. As this was a retrospective study using anonymized data, no individual consent for publication was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}